MedTrace Logo

Low Dose Bismuth Versus Lactobacillus Reuteri for H. Pylori Eradication

NCT03925818 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2019-04-26

No results posted yet for this study

Summary

This study investigates the efficacy of a b.i.d. quadruple therapy containing Pylera® or L. reuteri for H. pylori infection.

Conditions

  • Helicobacter Pylori Infection

Interventions

DRUG

Bismuth Subcitrate Potassium

Pylera capsules

DIETARY_SUPPLEMENT

Gastrus

Gastrus 1 tablet

Sponsors & Collaborators

  • Università degli Studi di Sassari

    lead OTHER

Principal Investigators

  • MARIA P Dore, MD, PhD · Università degli Studi di Sassari

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-29
Primary Completion
2018-11-29
Completion
2018-12-23

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03925818 on ClinicalTrials.gov